Noctrix Health, Inc.
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tonic Motor Activation (TOMAC) Therapy in Patients With Restless Legs Syndrome and Dopaminergic Augmentation (NCT07397247) | Noctrix Health, Inc. | 2026-04-01 |
| Response to an Investigational Device in Patients With Restless Legs Syndrome (NCT06866132) | Noctrix Health, Inc. | 2025-03-11 |
| A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS (NCT06076499) | Noctrix Health, Inc. | 2023-11-15 |
| Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS (NCT05214963) | Noctrix Health, Inc. | 2022-03-08 |
| Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS (NCT05196828) | Noctrix Health, Inc. | 2021-12-20 |
| Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction (NCT04698343) | Noctrix Health, Inc. | 2021-04-06 |
| Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome (NCT04700683) | Noctrix Health, Inc. | 2019-07-14 |
Track Noctrix Health, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.